Drug-induced taste and smell alterations: A casenon-case evaluation of an italian database of spontaneous adverse drug reaction reporting

Marco Tuccori, Francesco Lapi, Arianna Testi, Elisa Ruggiero, Ugo Moretti, Alfredo Vannacci, Roberto Bonaiuti, Luca Antonioli, Matteo Fornai, Giulio Giustarini, Carla Scollo, Tiberio Corona, Fernanda Ferrazin, Laura Sottosanti, Corrado Blandizzi

    Research output: Contribution to journalArticleAcademicpeer-review

    Abstract

    Background: The frequency and clinical features of drug-related taste and/or smell impairments are currently unclear. Objective: The aim of this study was to identify major drug classes associated with taste and smell alterations reported to the Italian spontaneous adverse drug reaction (ADR) reporting database. Methods: The association between drug and altered taste or smell was investigated by case/non-case methodology. The reporting odds ratio (ROR) was used as a measure of disproportionality. Cases were defined as patients with at least one ADR related to taste or smell impairments. The non-cases included all patients without any ADRs related to taste or smell alterations. Results: According to the selection criteria, 52 166 reports were included in the analysis. Overall, 182 cases of drug-related taste and/or smell dysfunctions were identified. Statistically significant unadjusted RORs were reported for macrolides (n = 31; 7.1; 95% CI 4.8, 10.5), terbinafine (the only drug reported within the group of antimycotics belonging to the Anatomical Therapeutic Chemical class D01AE) [n = 17; 76.4; 95% CI 44.0, 132.6], fluoroquinolones (n = 15; 1.7; 95% CI 1.0, 2.8) and protein kinase inhibitors (n = 10; 4.0; 95% CI 2.1, 7.7). When RORs were adjusted for sex and age category, the disproportion remained statistically significant for all of the previously mentioned drug classes. © 2011 Adis Data Information BV. All rights reserved.
    Original languageEnglish
    Pages (from-to)849-859
    Number of pages11
    JournalDrug Safety
    Volume34
    Issue number10
    DOIs
    Publication statusPublished - 1 Jan 2011

    Keywords

    • Antifungals
    • Dysgeusia
    • Dysosmia
    • Fluoroquinolones
    • Macrolides
    • Olfaction-disorders
    • Protein-kinase-inhibitors
    • Taste-disorders
    • Terbinafine
    • amoxicillin plus clavulanic acid
    • antifungal agent
    • azithromycin
    • beclometasone
    • ciprofloxacin
    • clarithromycin
    • dipeptidyl carboxypeptidase inhibitor
    • erlotinib
    • hydroxymethylglutaryl coenzyme A reductase inhibitor
    • imatinib
    • levofloxacin
    • lomefloxacin
    • macrolide
    • moxifloxacin
    • norfloxacin
    • protein kinase inhibitor
    • proton pump inhibitor
    • quinoline derived antiinfective agent
    • ramipril
    • roxithromycin
    • simvastatin
    • sunitinib
    • telithromycin
    • terbinafine
    • adult
    • aged
    • ageusia
    • anosmia
    • article
    • bronchitis
    • chronic bronchitis
    • clinical feature
    • data base
    • drug dose titration
    • drug withdrawal
    • dysgeusia
    • female
    • follow up
    • gastrointestinal stromal tumor
    • human
    • kidney cancer
    • major clinical study
    • male
    • methodology
    • priority journal
    • smelling disorder
    • taste disorder
    • unspecified side effect

    Fingerprint

    Dive into the research topics of 'Drug-induced taste and smell alterations: A casenon-case evaluation of an italian database of spontaneous adverse drug reaction reporting'. Together they form a unique fingerprint.

    Cite this